Role of 5-HT4 receptors in the mouse passive avoidance test1

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1115-1121

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a   Bartolini, Alessandro ^a  

^a Clinical Pharmacology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 3 ETHYL 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; DICYCLOVERINE; ONDANSETRON; PHYSOSTIGMINE; PIRACETAM; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; (ENDO N 8 METHYL 8 AZABICYCLO (3.2.1)OCT 3 YL) 2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1H BENZIMIDAZOL 1 CARBOXAMIDE; (ENDO N 8 METHYL 8 AZABICYCLO(3.2.1)OCT 3 YL) 2,3 DIHYDRO 3 ETHYL 2 OXO 1H BENZIMIDAZOL 1 CARBOXAMIDE; (ENDO-N-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL)-2,3-DIHYDRO-3-ETHYL-2-OXO-1H-BENZIMIDAZOL-1-CARBOXAMIDE; (ENDO-N-8-METHYL-8-AZABICYCLO-(3.2.1)OCT-3-YL)-2,3-DIHYDRO-3-ISOPROPYL-2-OXO-1H-BENZIMIDAZOL-1-CARBOXAMIDE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; BENZIMIDAZOLE DERIVATIVE; FUSED HETEROCYCLIC RINGS; INDOLE DERIVATIVE; SEROTONIN 4 RECEPTOR; SEROTONIN RECEPTOR; SULFONAMIDE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY CONSOLIDATION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PERFORMANCE; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED DISORDER; MEMORY; PHYSIOLOGY;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; BENZIMIDAZOLES; BICYCLO COMPOUNDS, HETEROCYCLIC; INDOLES; MALE; MEMORY; MICE; ONDANSETRON; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SULFONAMIDES;

EID: 0032158693     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Andrade R and Chaput Y (1991) 5-Hydroxytryptamine4.like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Eip Ther 257:930-937.
2. Ansanay H, Dumuis A, Sebben M, Bockaert J and Fagni L (1995) cAMP- dependent, long-lasting inhibition of a K+ current in mammalian neurones. Proc Natl Acad Sei USA 92:6635-6639.
3. Barnes NM, Costall B, Naylor RJ, Williams TJ and Wishchik CM (1990) Noriml densities of 5-HT3 receptor recognition sites in Alzheimer's disease. Neurorepo't 1:253-254.
4. Bockaert J, Sebben M and Dumuis A (1990) Pharmacological characterization of 5-HT4 receptors positively coupled to adenylate cyclase in adult guinea-pig hippocampal membranes. Mol Pharmacol 37:408-411.
5. Bockaert J, Ansanay H, Waeber C, Sebben M, Fagni L and Dumuis A (1994a) 5- HT4 receptors. Potential therapeutic implications in neurology and psychiatry. CNS Drugs 1:6-15.
6. Bockaert J, Ansanay H, Waeber C, Dumuis A and Fagni L (1994b) 5-HT4 receptors: Brain distribution of long term blockade of K+ channels in cultured neurones. s, Third IUPHAR Satellite Meeting on Serotonin, p 20, Chicago, IL.
7. Boddeke HWGM and Kalkman HO (1990) Zacopride and BRL 24924 induce an increase in EEG energy in rats. Br J Pharmacol 101:281-284.
8. Bonhaus DW, Loury DN, Jakeman LB, DeSouza A, Eglen RM and Wong EH (1993) (3H]B1MU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selective y labels o-2 binding sites in guinea-pig hippocampus. J Pharmacol Exp Ther 267: 961-970.
9. Bonhaus DW, Loury DN, Jakeman LB, Hsu SA, To ZP, Zeitung KD, Eglen RM and Wong EH (1994) [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels o! but not cr2 binding sites in guinea-pig brain. J Pharmacol Exp Tht'.r 271:484-493
10. Buchheit KH, Gamse R and Pfannkuche H-J (1991) SDZ 205557, a selective antag-onist at 5-HT4-receptors in the isolated guinea pig ileum. Eur J Pharmacol 20'0: 373-374.
11. Consolo S, Arnaboldi S, Giorgi S, Russi G and Ladinsky H (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in frontal cortex. NeuroRepo.-t 5:1230-1232.
12. Coyle MJ (1995) A cholinergic hypothesis for Alzheimer's disease, in Learning and Memory Molecular Bases (Meyer L and Nordeberg GH eds) pp 11-32, Pergamcn Press, London.
13. Dumuis A, Bouhelal R, Sebben M, Cory R and Bockaert J (1988) A nonclassicul 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880-887.
14. Dumuis A, Sebben M and Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the nonclassical 5-HT (5-HT4) receptor coupled to adenylate cyclase in neurones. Naunyn-Schmied Arch Pharmacol 340:403-410.
15. Dumuis A, Sebben M, Monferini E, Nicola M, Turconi M, Ladinsky H and Bockaert J (1991) Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn-Schmied Arch Pharmacol 343:245-251.
16. Fagni L, Dumuis A, Sebben M and Bockaert J (1992) The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br J Pharmacol 105:973-979.
17. Fontana DJ, Wong EHF, Clark RD, Bonhaus D, Leung E and Eglen RM (1994) Pro-cognitive effects of RS 66331, a mixed 5-HT3 receptor antagonist/5-HT4 agonist. s, Third IUPHAR Satellite Meeting on Serotonin, p. 57, Chicago, IL.
18. Fontana DJ, Daniels SE, Wong EHF, Clark RD and Eglen RM (1997) The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 36:689-696.
19. Frey U, Huang Y-Y and Handel ER (1993) Effects of cAMP stimulate a late stage of LTP in hippocampal CA1 neurones. Science 260:1661-1664.
20. Gale JD, Green A, Darton J, Sargent RS, Clayton NM and Bunce KT (1994) G R 125487: a 5-HT4 receptor antagonist with a long duration of action in vivo. Br J Pharmacol 113:119P.
21. Galeotti N, Fanfani L, Meoni P, Ghelardini C, Giotti A, Gualtieri F, Romanelli MN and Bartolini A (1993) Effect of the 5HT4 agonists metoclopramide and Compound 1 on learning and memory. J Auton Nervous System 43:(Suppl)78-79.
22. Ghelardini C, Galeotti N, Casamenti F, Malmberg-Aiello P, Pepeu G, Gualtieri F and Bartolini A (1996) Central cholinergic antinociception induced by 5-HT4 agonists: BIMU 1 and BIMU 8. Life Sei 58:2297-2309.
23. Grossman CJ, Kilpatrick GJ and Bunce KT (1993) Development of a radioligand binding assay for the 5-HT4 receptor in guinea-pig and rat brain. Br J Pharmacol 109:618-624.
24. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
25. Jarvik ME and Kopp R (1.967) An improved one-trial passive avoidance learning situation. Psychol Rep 21:221-224.
26. Letty S, Child R, Dumuis A, Pantaloni A, Bockaert J and Rondouin G (1997) 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology 36:681687.
27. Marchetti-Gauthier E, Roman FS, Dumuis A, Bockaert J and Soumireu-Mourat B (1997) BIMU 1 increases associative memory in rats by activating 5-HT4 receptors. Neuropharmacology 36:697-706.
28. Monferini E, Gaetani P, Rodriguez Y, Baena R, Parenti M, Zocchetti A and Rizzi CA (1993) Pharmacological characterization of the 5-hydroxvtryptamine receptor coupled to adenylyl cyclase stimulation in human brain. Life Sei 52:61-65.
29. Reynolds GP, Mason SL, Meldrum A, De Keczer S, Parnes H, Eglen RM and Wong EHF (1995) 5-hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol 114:993-998
30. Romanelli MN, Ghelardini C, Dei S, Matucci R, Mori F, Scapecchi S, Teodori E, Bartolini A, Galli A, Giotti A and Gualtieri F (1993) Synthesis and biological activity of a series of aryl tropanyl esters and amides chemically related to lH-indole-3-carboxylic acid endo 8-methyl-azabicyclo[3.2.1]oct-3-yl ester: develop-ment of a 5-HT4 agonist endowed with potent antinociceptive activity. Arzneim ForschlDrug Res 43:(II)8 913-918.
31. Turconi M, Nicola M, Quintero MG, Maiocchi L, Micheletti R, Giraldo E and Donetti A (1990) Synthesis of a new class of 2,3-dihydro-2-oxo-l//-benzimidazole-lcarboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. J MedChem 33:2101-2108.
32. Turconi M, Schiantarelli P, Borsini F, Rizzi ÇA, Ladinsky H and Donetti A (1991) Azabicycloalkyl benzimidazolones: interaction with serotoninergic 5-HT3 and 5-HT4 receptors and potential therapeutic implications. Drugs Fut 16:1011-1026.
33. Vaught J, Pelley K, Costa LG, Sether P and Enna SJ (1985) A comparison of the antinociceptive responses to GABA-receptor agonists TRIP and baclofen. Neuropharmacology 24:211-216.
34. Waeber C, Sebben M, Grossman C, Javoy-Agid F and Dumuis A (1993) [3H]GR 113808 labels receptors in the human and guinea-pig brain. Neuroreport 4:1239-1242.
35. Weatherspoon JK, Gonzalez-Alvear GM and Werling LL (1997) Regulation of [3H]norepinephrine release from guinea-pig hippocampus by o-2 receptors. Eur J Pharmacol 326:133-138.